# DICLOFENAC POTASSIUM
> **ANDA217010** · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA · Approved 2025-08-29
## Drug
- **FDA Application Number:** ANDA217010
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DICLOFENAC POTASSIUM
- **Generic name:** DICLOFENAC POTASSIUM
- **Active ingredients:** DICLOFENAC POTASSIUM
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UMEDICA
- **Manufacturer:** Nivagen Pharmaceuticals, Inc.
- **First approval:** 2025-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217010)
---
*MORVS · CC0 1.0*